col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


39 Ergebisse       Seite 1

 [1] 
Ivyspring International Publisher: Theranostics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jun―12 SUMOylation of SARS-CoV-2 spike protein is a key target for broad-spectrum antiviral therapy Xinyu Wang, Gaowei Hu, Yupeng Shao, Zhongwei Dong, Lina Liu, Yixuan Wang, et al. (+7)
2 [GO] 2025―Apr―28 Investigating post-infection anxiety- and depression-like behaviors in a SARS-CoV-2 mouse model Qian Ge, Shan Zhou, Jose Porras, Panfeng Fu, Ting Wang, Jianyang Du, Kun Li
3 [GO] 2023―Sep―27 Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection Ang Gao, Yunsheng Chen, Hui Liang, Xinyuan Cui, Amin Zhang, Daxiang Cui
4 [GO] 2023―Jun―14 The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype Xiuli Zhang, Yuan Sh, Jierong Dong, Zhongqing Chen, Feitong Hong
5 [GO] 2023―Jan―05 Dynamic white matter changes in recovered COVID-19 patients: a two-year follow-up study Sihong Huang, Xianglin Zhou, Wei Zhao, Yanyao Du, Danhui Yang, Yijie Huang, et al. (+5)
6 [GO] 2022―Nov―29 Circulating microRNAs as emerging regulators of COVID-19 Yu Liang, Dan Fang, Xiaojun Gao, Xin Deng, Ni Chen, Jianbo Wu, et al. (+2)
7 [GO] 2022―Jul―19 DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach Achut Prasad Silwal, Siddhartha Kalpa Samadhi Thennakoon, Satya Prakash Arya, Rick Mason Postema, Raunak Jahan, Chien Minh Tran Phuoc, Xiaohong Tan
8 [GO] 2022―Jun―14 Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants Sandro Satta, Fahimeh Shahabipour, Wei Gao, Steven R. Lentz, Stanley Perlman, Nureddin Ashammakhi, Tzung Hsiai
9 [GO] 2022―Mai―25 The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response Francisco J. Enguita, Ana Lúcia Leitão, J. Tyson McDonald, Viktorija Zaksas, Saswati Das, Diego Galeano, et al. (+10)
10 [GO] 2022―Mrz―07 Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination Xiaomei Zhang, Mei Zheng, Hongye Wang, Haijian Zhou, Te Liang, Jiahui Zhang, et al. (+16)
11 [GO] 2022―Mrz―07 An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages Sandro Satta, Zhaojie Meng, Rebecca Hernandez, Susana Cavallero, Tong Zhou, Tzung K. Hsiai, Changcheng Zhou
12 [GO] 2021―Nov―10 Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2 Kuan-Ying A. Huang, Daming Zhou, Tiong Kit Tan, Charles Chen, Helen M. E. Duyvesteyn, Yuguang Zhao, et al. (+23)
13 [GO] 2021―Jul―27 Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19 Chong Wang, Xufang Li, Wanshan Ning, Sitang Gong, Fengxia Yang, Chunxiao Fang, et al. (+11)
14 [GO] 2021―Jul―27 Endothelial cell infection and dysfunction, immune activation in severe COVID-19 Zhongnan Qin, Fengming Liu, Robert Blair, Chenxiao Wang, Haoran Yang, Joseph Mudd, et al. (+17)
15 [GO] 2021―Jul―27 Environmentally-induced mdig contributes to the severity of COVID-19 through fostering expression of SARS-CoV-2 receptor NRPs and glycan metabolism Qian Zhang, Priya Wadgaonkar, Liping Xu, Chitra Thakur, Yao Fu, Zhuoyue Bi, et al. (+5)
16 [GO] 2021―Jul―27 Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities Tiantian Yan, Rong Xiao, Nannan Wang, Ruoyu Shang, Guoan Lin
17 [GO] 2021―Jun―02 TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions Jinrui Xu, Yuquan Yang, Zhaoyuan Hou, Hao Jia, Yujiong Wang
18 [GO] 2021―Mai―06 A SCID mouse-human lung xenograft model of SARS-CoV-2 infection Wenkun Fu, Wei Wang, Lunzhi Yuan, Yanzhen Lin, Xiumin Huang, Rirong Chen, et al. (+19)
19 [GO] 2021―Apr―27 The therapeutic potential of inorganic polyphosphate: A versatile physiological polymer to control coronavirus disease (COVID-19) Hadrian Schepler, Xiaohong Wang, Meik Neufurth, Shunfeng Wang, Heinz C. Schröder, Werner E. G. Müller
20 [GO] 2021―Feb―19 MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein Byoung Kwon Park, Jinsoo Kim, Sangkyu Park, Dongbum Kim, Minyoung Kim, Kyeongbin Baek, et al. (+5)
21 [GO] 2020―Dez―16 Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19 Zhao Zhang, Liyan Guo, Xiaoxia Lu, Che Zhang, Li Huang, Xianfeng Wang, et al. (+28)
22 [GO] 2020―Dez―16 Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials Young Joo Han, Keum Hwa Lee, Sojung Yoon, Seoung Wan Nam, Seohyun Ryu, Dawon Seong, et al. (+19)
23 [GO] 2020―Dez―16 The 2020 race towards SARS-CoV-2 specific vaccines Tomasz M. Karpiński, Marcin Ożarowski, Agnieszka Seremak-Mrozikiewicz, Hubert Wolski, Donald Wlodkowic
24 [GO] 2020―Nov―06 COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges Anup S. Pathania, Philip Prathipati, Bakrudeen AA. Abdul, Srinivas Chava, Santharam S. Katta, Subash C. Gupta, et al. (+5)
25 [GO] 2020―Okt―28 Immunopathogenesis and treatment of cytokine storm in COVID-19 Jae Seok Kim, Jun Young Lee, Jae Won Yang, Keum Hwa Lee, Maria Effenberger, Wladimir Szpirt, et al. (+2)
26 [GO] 2020―Okt―28 Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein Lin Wang, Junhu Zhou, Qixue Wang, Yunfei Wang, Chunsheng Kang
27 [GO] 2020―Aug―10 Emerging evidence of myocardial injury in COVID-19: A path through the smoke Gregorio Tersalvi, Giacomo Veronese, Dario Winterton
28 [GO] 2020―Jul―30 Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease Jiatian Cao, Yan Zheng, Zhe Luo, Zhendong Mei, Yumeng Yao, Zilong Liu, et al. (+9)
29 [GO] 2020―Jul―02 COVID-19: Progress in diagnostics, therapy and vaccination Xue Liu, Chao Liu, Gang Liu, Wenxin Luo, Ningshao Xia
30 [GO] 2020―Jul―02 SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy Prasun K. Datta, Fengming Liu, Tracy Fischer, Jay Rappaport, Xuebin Qin
31 [GO] 2020―Jun―15 Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19 Manuela Teresa Raimondi, Francesca Donnaloja, Bianca Barzaghini, Alberto Bocconi, Claudio Conci, Valentina Parodi, et al. (+2)
32 [GO] 2020―Jun―15 Radiomics Analysis of Computed Tomography helps predict poor prognostic outcome in COVID-19 Qingxia Wu, Shuo Wang, Liang Li, Qingxia Wu, Wei Qian, Yahua Hu, et al. (+8)
33 [GO] 2020―Jun―15 Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2 Dandan Li, Jiawei Zhang, Jinming Li
34 [GO] 2020―Mai―24 Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study Peng Peng Xu, Rong Hua Tian, Song Luo, Zi Yue Zu, Bin Fan, Xi Ming Wang, et al. (+23)
35 [GO] 2020―Mai―24 Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China Lingli Li, Lian Yang, Shan Gui, Feng Pan, Tianhe Ye, Bo Liang, et al. (+2)
36 [GO] 2020―Mai―03 CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients Fengjun Liu, Qi Zhang, Chao Huang, Chunzi Shi, Lin Wang, Nannan Shi, et al. (+13)
37 [GO] 2020―Mai―03 Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients Qian Yu, Yuancheng Wang, Shan Huang, Songqiao Liu, Zhen Zhou, Shijun Zhang, et al. (+4)
38 [GO] 2020―Mai―03 Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients Rasha Itani, Mansour Tobaiqy, Achraf Al Faraj
39 [GO] 2020―Apr―11 CT Scans of Patients with 2019 Novel Coronavirus (COVID-19) Pneumonia Wei Zhao, Zheng Zhong, Xingzhi Xie, Qizhi Yu, Jun Liu
 [1] 

39 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec